Table 5 Changes in Utilization and Cost Attributable to Mail Order. Drugs for Chronic Use and Dual-Eligible
| Â | Drugs for Chronic Use (n = 304,102) | Dual-Eligible (n = 199,902) | Dual-Eligible Using Drugs for Chronic Use (n = 96,868) | |||
|---|---|---|---|---|---|---|
| Â | Mean | Std Dev | Mean | Std Dev | Mean | Std Dev |
Day supply in community pharmacy | 687.6 | 523.2 | 758.8 | 527.8 | 807.0 | 526.7 |
Estimated day supply in mail order pharmacy | 722.4 | 525.2 | 794.2 | 530.1 | 841.8 | 528.7 |
Difference | 34.8 | Â | 35.4 | Â | 34.8 | Â |
% Difference | 5.1% | Â | 4.7% | Â | 4.3% | Â |
Drug product cost in community pharmacy | $1,103.65 | $2,918.83 | $1,563.01 | $7,114.38 | $1,219.59 | $2,139.52 |
Estimated drug product cost in mail order pharmacy | $1,157.30 | $3,039.04 | $1,635.63 | $7,531.51 | $1,272.62 | $2,226.44 |
Mail order cost reduction required to become cost neutral | $53.65 | Â | $72.62 | Â | $53.03 | Â |
% Difference | 4.9% | Â | 4.7% | Â | 4.4% | Â |